Novartis (NOTA) Q3 2024 Earnings Report
27 Followers
DE:NOTA Q3 2024 EPS Results
- Actual EPS
- EUR 1.83
- Consensus EPS
- EUR 1.72
- Beat/Miss
- Beat by +EUR 0.11
- One Year Ago EPS
- EUR 1.55
DE:NOTA Q3 2024 Revenue Results
- Actual Revenue
- EUR 11.52B
- Expected Revenue
- EUR 11.37B
- Beat/Miss
- Beat by +EUR 151.70M
- YoY Revenue Growth
- +10.52%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 10/29/2024
- Time
- Before Open
- Conference Call
- Tuesday, October 29, 2024
DE:NOTA Upcoming Earnings
Novartis's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q3 2024 Earnings Call Audio
DE:NOTA Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:NOTA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 2.00- | 1.8 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 2.022.19 | 2 | 9.33% (+0.19) | |
| Jul 21, 2026 | 2026 (Q2) | 1.932.14 | 2.15 | -0.41% (-0.01) | |
| Apr 28, 2026 | 2026 (Q1) | 1.861.77 | 2.03 | -12.72% (-0.26) | |
| Feb 04, 2026 | 2025 (Q4) | 1.761.80 | 1.76 | 2.53% (+0.04) | |
| Oct 28, 2025 | 2025 (Q3) | 2.022.00 | 1.83 | 9.22% (+0.17) | |
| Jul 17, 2025 | 2025 (Q2) | 2.092.15 | 1.75 | 22.84% (+0.40) | |
| Apr 29, 2025 | 2025 (Q1) | 1.882.03 | 1.6 | 26.67% (+0.43) | |
| Jan 31, 2025 | 2024 (Q4) | 1.601.76 | 1.36 | 29.41% (+0.40) | |
| Oct 29, 2024 | 2024 (Q3) | 1.721.83 | 1.55 | 18.39% (+0.28) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
